FT. MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today announced that the New York State Department of Health (NYSDOH) has granted the ...
New ctDNA-based test offers a flexible, guideline-driven solution for patients with advanced solid tumors when tissue is limited or unavailable NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of ...
“Speed is the new currency of business,” said Marc Benioff, CEO of Salesforce. In my experience, however, speed without quality is nothing but a fast track to failure. This delicate balance between ...
Zacks Investment Research on MSN
FLGT to acquire Bako & StrataDx assets to expand pathology platform
Fulgent Genetics, Inc. FLGT recently entered into an agreement to acquire selected assets of Bako Diagnostics and to acquire StrataDx — two well-known pathology testing companies — in a combined ...
In 2020, it was projected that U.S. companies lost over $2 trillion due to poor-quality software. These costs came from unsuccessful projects, legacy software and operational failures, adding to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback